Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Societe Francaise d'Oncologie Pediatrique
Authors:
Open Access
- 15 April 1993
- journal article
- Published by American Society of Hematology in Blood
- Vol. 81 (8) , 2003-2006
Abstract
The very high cure rate in advanced B-cell non-Hodgkin's lymphoma in children using intensive multiagent therapy has been previously reported by the French Societe Francaise d'Oncologie Pediatrique lymphoma Malin B type (LMB) group. To address the issue of salvageability in an unselected group of patients who had all received the same front-line therapy, the outcome of relapses following the LMB 84 (216 patients) protocol have been reviewed. Fourteen percent of patients achieving complete remission (CR) relapsed, ie, 27 of 195. Relapse sites comprised the central nervous system (CNS) alone (6 cases), lung or mediastinum (2 cases), abdomen (8 cases), head and neck (2 cases), or multifocal (9 cases). There were three early deaths due to disease. Twenty-four patients received rescue chemotherapy regimens and 15 were treated with high-dose chemotherapy and bone marrow rescue (1 allogeneic). Of these, 9 were in second CR, 4 in second partial remission, and 2 treated during progressive disease. One died in CR from treatment-related toxicity. Ten relapsed postbone marrow transplant and 4 are alive disease free and probably cured. Two of the long-term survivors had some delay during initial chemotherapy due to toxicity and two were isolated CNS relapses. Twelve of 27 patients did not proceed to megatherapy (12 of 12 died).Keywords
This publication has 13 references indexed in Scilit:
- Outcome in stage III non-Hodgkin's lymphoma in children (UKCCSG study NHL 86) – how much treatment is needed?British Journal of Cancer, 1991
- Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.Journal of Clinical Oncology, 1986
- High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study.Journal of Clinical Oncology, 1986
- Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society.Journal of Clinical Oncology, 1986
- The role of massive therapy with autologous bone marrow transplantation in Burkitt's lymphomaClinics in Haematology, 1986
- Curability of Burkitt's lymphoma with high-dose cyclophosphamide-high-dose methotrexate therapy and intrathecal chemoprophylaxis.Journal of Clinical Oncology, 1985
- Abdominal Burkitt-type lymphomas in AlgeriaBritish Journal of Cancer, 1984
- Central nervous system involvement in American Burkitt's lymphoma.Journal of Clinical Oncology, 1983
- Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian childrenBritish Journal of Cancer, 1982
- Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapseCancer, 1978